Latigo Biotherapeutics logo

Latigo Biotherapeutics Funding & Investors

Thousand Oaks, CA

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependence or tolerability.

latigobio.com

Total Amount Raised: $300,000,000

Latigo Biotherapeutics Funding Rounds

  • Series B

    $150,000,000

    Series B Investors

    Blue Owl
    KERN CAPITAL HOLDINGS PTY
    Sanofi
    Qatar Investment Authority
    Deep Track Capital
    UPMC
    Rock Springs Capital
    Access Industries
    Cormorant Asset Management
    Alexandria Venture Investments
    Westlake Village BioPartners
    5am Ventures
    Foresite Capital
  • Series A

    $135,000,000

    Series A Investors

    5am Ventures
    Foresite Capital
    Westlake Village BioPartners
    Corner Ventures
  • Series Unknown

    $15,000,000

    Series Unknown Investors

    Corner Ventures
Funding info provided by Diffbot.